Assessment of New Biomarkers in the Management and Triage of Patients With Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome.
Not Applicable
Completed
- Conditions
- Coronary Syndrome
- Registration Number
- NCT00769574
- Lead Sponsor
- Assistance Publique Hopitaux De Marseille
- Brief Summary
To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 143
Inclusion Criteria
- subjects over 18 years,
- subject about having a chest pain of coronary syndrome,
- subject about not having received heparin or LMWH
Exclusion Criteria
- subject minor
- subject without informed consent,
- subject after receiving an anticoagulant treatment,
- transplanted heart, kidney or liver
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method To assess diagnostic and prognostic value of new biomarkers in patients admitted for suspicion of non ST elevation acute coronary syndrome (NSTE ACS). 24 months
- Secondary Outcome Measures
Name Time Method Compare the characteristics of biological markers to those of usual or innovative markers 24 months
Trial Locations
- Locations (1)
Hôpital de la Timone- Service cardiologie A
🇫🇷Marseille, France
Hôpital de la Timone- Service cardiologie A🇫🇷Marseille, France